![Stephen Lam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Stephen Lam is currently Chief Executive Officer at Tanvex BioPharma, Inc. since 2024.
Mr. Lam also serves as Secretary, Chief Executive & Financial Officer at Tanvex BioPharma USA, Inc. Formerly, Mr. Lam was Vice President, General Manager & Head-Biologics at Thermo Fisher Scientific, Inc.
Actieve functies van Stephen Lam
| Bedrijven | Functie | Begin |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Algemeen Directeur | 05-09-2024 |
Tanvex BioPharma USA, Inc.
 Tanvex BioPharma USA, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Algemeen Directeur | - |
Eerdere bekende functies van Stephen Lam
| Bedrijven | Functie | Einde |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Tanvex BioPharma, Inc.
 Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer | Health Technology |
Tanvex BioPharma USA, Inc.
Tanvex BioPharma USA, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
